- American children under the age of 12 are taking GLP-1 obesity drugs at 300 times the rate compared to seven years ago, according to a new study.
- More than 20,000 children aged 8 to 11 have taken GLP-1 medications since 2019, with most suffering from severe obesity and related health conditions.
- Although the FDA has not approved GLP-1 drugs for children under 12, doctors are legally prescribing them off-label based on clinical guidelines.
- Medical experts suggest the benefits of GLP-1s may outweigh potential risks by preventing severe long-term conditions like diabetes and heart disease.
- Clinical trials are actively underway to evaluate the safety and efficacy of GLP-1 treatments in children as young as six years old.
IN FULL
